Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Tables)

v3.23.3
Share-based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Information about Incentive Plan

The following table contains information about the 2019 Plan as of September 30, 2023:

 

    Awards     Awards           Awards  
   

Reserved for

Issuance

    Issued & Outstanding    

Awards

Exercised

   

Available for

Grant

 
2019 Plan(1)     871,429       689,783       19,683       161,963  
Awards granted outside of the 2019 Plan(2)     -       48,401       29,880       -  

 

(1) Includes incentive stock options and restricted stock units discussed below.
   
(2) Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.
Schedule of Incentive Stock Option Activity

The following table summarizes the Company’s incentive stock option activity and related information for the period ended September 30, 2023:

 

                Weighted  
          Weighted     Average  
          Average     Contractual  
    Number of     Exercise     Term in  
    Options     Price     Years  
Outstanding at January 1, 2023     524,937     $ 2.351416       8.38  
Granted     117,532       2.06041       10.0  
Exercised     (10,000 )     1.75        
Forfeited                  
Cancelled     (13,149 )     2.00        
Expired     (4,287 )     1.40        
Outstanding at September 30, 2023     615,033     $ 2.319728       8.05  
Exercisable at September 30, 2023     362,533     $ 1.801861       7.20  
Schedule of Assumptions used in Share-based Compensation

 

Volatility     257.64-258.01 %
Risk-free interest rate     4.21-4.42 %
Dividend yield     0.0 %
Expected term     5 - 5.50 years  
Schedule of Restricted Stock Units Granted

          Weighted  
          Average  
    Number of     Grant Date  
    Units     Fair Value  
Outstanding at January 1, 2023     90,432     $ 1.98211  
Granted     37,037       1.35  
Exercised and converted to common shares     (26,698 )     2.04313  
Forfeited     (7,500 )     1.82  
Outstanding at September 30, 2023     93,271     $ 1.72667  
Exercisable at September 30, 2023     27,946     $ 1.66430  
Summary of Common Stock Warrants

The following table shows a summary of common stock warrants through September 30, 2023:

 

          Weighted     Weighted  
          Average     Average  
    Number of     Exercise     Contractual  
    Warrants     Price     Term in Years  
Outstanding at January 1, 2023     3,637,190     $ 5.16281       3.65  
Granted                  
Exercised     (112,466 )     0.55        
Forfeited                  
Cancelled     (81,820 )     0.91        
Expired                  
Outstanding at September 30, 2023     3,442,904     $ 5.414793       3.09  
Exercisable at September 30, 2023     3,442,904     $ 5.414793       3.09